Clinuvel Pharmaceuticals to Prioritize Programs With Highest Likelihood of Regulatory Approval, Commercial Success
Clinuvel Pharmaceuticals to Prioritize Programs With Highest Likelihood of Regulatory Approval, Commercial Success
Clinuvel制药公司将优先考虑最有可能获得监管批准和商业成功的项目
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间